SEC Form 4 · accession 0001140361-17-010313
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathy Yi
Officer — Senior VP & CFO
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $4.55 | Feb 28, 2017 | A | 200,000 | A | — | Feb 27, 2027 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from February 27, 2017, and the balance of the shares will vest and become exercisable in 36 equal monthly installments upon her completion of each additional month of service thereafter.